Marcelo F Montenegro Selected Research

Marcelo F Montenegro Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2018 - 07/2011
5	Pulmonary Embolism 02/2012 - 02/2008
4	Hypotension (Low Blood Pressure) 12/2013 - 02/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 10/2016
3	Inflammation (Inflammations) 08/2020 - 08/2010
3	Pre-Eclampsia (Preeclampsia) 01/2019 - 08/2010
3	Renovascular Hypertension (Goldblatt Syndrome) 10/2015 - 10/2010
2	Sepsis (Septicemia) 12/2015 - 08/2010
2	Pulmonary Hypertension 12/2010 - 10/2008
1	Metabolic Diseases (Metabolic Disease) 12/2019
1	Fatty Liver 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Chronic Periodontitis 06/2017
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Sudden Infant Death (SID) 12/2015
1	Chronic Disease (Chronic Diseases) 12/2015
1	Ischemia 12/2015
1	Lung Injury 12/2010
1	Hypoxia (Hypoxemia) 02/2008
1	Lead Poisoning (Poisoning, Lead) 07/2006
1	Bone Diseases (Bone Disease) 01/2006
1	Multiple Myeloma 01/2006

Drug/Important Bio-Agent (IBA)

13	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2020 - 10/2008
10	NitritesIBA 12/2019 - 10/2008
7	NitratesIBA 12/2019 - 12/2013
7	Sodium NitriteIBA 10/2015 - 07/2011
6	Antihypertensive Agents (Antihypertensives)IBA 10/2015 - 07/2011
4	Nitric Oxide Synthase (NO Synthase)IBA 12/2019 - 12/2010
4	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 07/2011
4	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019 - 12/2013
4	AntioxidantsIBA 08/2015 - 12/2010
3	Sildenafil Citrate (Viagra)FDA Link 12/2010 - 10/2008
2	Angiotensin IIIBA 01/2018 - 01/2016
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2017 - 12/2010
2	Xanthine DehydrogenaseIBA 08/2015 - 06/2014
2	Drinking WaterIBA 08/2014 - 05/2012
2	3- (4- Amino- 5- cyclopropylpyrimidine- 2- yl)- 1- (2- fluorobenzyl)- 1H- pyrazolo(3,4- b)pyridineIBA 07/2009 - 02/2008
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 07/2009 - 01/2006
1	graphene oxideIBA 08/2020
1	AnionsIBA 12/2019
1	AMP-Activated Protein KinasesIBA 01/2019
1	ResveratrolIBA 01/2019
1	Esomeprazole (Nexium)FDA Link 01/2019
1	Heme Oxygenase-1IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Toll-Like Receptor 4IBA 12/2015
1	HMGB1 Protein (HMG1)IBA 12/2015
1	Saquinavir (Invirase)FDA Link 12/2015
1	Peptide Hydrolases (Proteases)FDA Link 12/2015
1	DisulfidesIBA 12/2015
1	CathepsinsIBA 12/2015
1	HIV Protease InhibitorsIBA 12/2015
1	S-NitrosothiolsIBA 10/2015
1	Desoxycorticosterone Acetate (DOCA)FDA Link 08/2015
1	Desoxycorticosterone (Deoxycorticosterone)IBA 08/2015
1	Lipid PeroxidesIBA 08/2015
1	SaltsIBA 08/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2015
1	8-epi-prostaglandin F2alphaIBA 08/2015
1	Angiotensin IIBA 08/2014
1	Superoxides (Superoxide)IBA 06/2014
1	tempolIBA 12/2013
1	arginine methyl esterIBA 12/2013
1	Losartan (Cozaar)FDA LinkGeneric 02/2012
1	S-methylisothiopseudouroniumIBA 12/2010
1	QuercetinIBA 10/2010
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2010
1	L-SelectinIBA 08/2010
1	Adenosine Triphosphate (ATP)IBA 08/2010
1	propargylglycineIBA 08/2010
1	G-Protein-Coupled Receptor Kinase 2IBA 08/2010
1	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 08/2010
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2010
1	Hemoglobins (Hemoglobin)IBA 08/2010
1	Matrix Metalloproteinases (MMPs)IBA 07/2009
1	GuanosineIBA 10/2008
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 10/2008
1	Thiobarbituric Acid Reactive SubstancesIBA 10/2008
1	Soluble Guanylyl CyclaseIBA 02/2008
1	Porphobilinogen Synthase (delta-Aminolevulinate Dehydratase)IBA 07/2006

Therapy/Procedure

2	Therapeutics 12/2015 - 02/2008
1	Oral Administration 08/2015
1	Surgical Instruments (Clip) 08/2014
1	Punctures 08/2010
1	Ligation 08/2010